Parkinson David Ross 4
4 · ESSA Pharma Inc. · Filed Jan 5, 2023
Insider Transaction Report
Form 4
ESSA Pharma Inc.EPIX
Parkinson David Ross
DirectorPresident and CEO
Transactions
- Purchase
Common Shares
2022-12-30$2.60/sh+3,067$7,974→ 56,542 total - Purchase
Common Shares
2022-12-22$2.39/sh+21,367$51,067→ 53,475 total
Footnotes (1)
- [F1]The amount reflects the acquisition of shares pursuant to the ESSA Pharma Inc. Employee Stock Purchase Plan.